Informa plc (LON:INF - Get Free Report) insider Stephen A. Carter sold 406,936 shares of the company's stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of GBX 865 ($11.43), for a total transaction of £3,519,996.40 ($4,649,929.19).
Informa Trading Down 0.7%
INF traded down GBX 6 ($0.08) on Friday, reaching GBX 862.20 ($11.39). 864,594,438 shares of the company traded hands, compared to its average volume of 16,898,535. Informa plc has a one year low of GBX 634.20 ($8.38) and a one year high of GBX 911.60 ($12.04). The firm has a fifty day simple moving average of GBX 815.93 and a two-hundred day simple moving average of GBX 798.58. The company has a market cap of £11.35 billion, a P/E ratio of 37.13, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12. The company has a quick ratio of 1.70, a current ratio of 0.56 and a debt-to-equity ratio of 31.98.
Informa (LON:INF - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The company reported GBX 30.10 ($0.40) EPS for the quarter. Informa had a net margin of 9.30% and a return on equity of 4.75%. As a group, equities research analysts expect that Informa plc will post 59.3240265 earnings per share for the current year.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on INF shares. Shore Capital restated a "buy" rating and set a GBX 930 ($12.29) target price on shares of Informa in a research report on Friday, May 23rd. JPMorgan Chase & Co. assumed coverage on shares of Informa in a report on Tuesday. They issued an "overweight" rating and a GBX 1,020 ($13.47) target price for the company.
View Our Latest Report on Informa
About Informa
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
Recommended Stories
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.